BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11206575)

  • 1. An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision.
    Lee YS; Kim ST; Kim GW; Lee M; Park JS
    Biochem Cell Biol; 2000; 78(6):653-8. PubMed ID: 11206575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutant loxP containing part of long terminal repeat of HIV-1 in spacer region: presentation of possible target site for antiviral strategy using site-specific recombinase.
    Lee Y; Park J
    Biochem Biophys Res Commun; 1998 Dec; 253(3):588-93. PubMed ID: 9918772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 proviral DNA excision using an evolved recombinase.
    Sarkar I; Hauber I; Hauber J; Buchholz F
    Science; 2007 Jun; 316(5833):1912-5. PubMed ID: 17600219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Cre-loxP interaction in the major groove: hint for structural distortion of mutant Cre and possible strategy for HIV-1 therapy.
    Kim ST; Kim GW; Lee YS; Park JS
    J Cell Biochem; 2001; 80(3):321-7. PubMed ID: 11135361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination.
    Missirlis PI; Smailus DE; Holt RA
    BMC Genomics; 2006 Apr; 7():73. PubMed ID: 16595017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.
    Saraf-Levy T; Santoro SW; Volpin H; Kushnirsky T; Eyal Y; Schultz PG; Gidoni D; Carmi N
    Bioorg Med Chem; 2006 May; 14(9):3081-9. PubMed ID: 16412655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages.
    Sauer B; McDermott J
    Nucleic Acids Res; 2004; 32(20):6086-95. PubMed ID: 15550568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication by the Cre-loxP hammerhead ribozyme.
    Habu Y; Miyano-Kurosaki N; Takeuchi H; Matsumoto N; Tamura Y; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):723-6. PubMed ID: 11563101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA.
    Meinke G; Karpinski J; Buchholz F; Bohm A
    Nucleic Acids Res; 2017 Sep; 45(16):9726-9740. PubMed ID: 28934476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein.
    Hoess R; Abremski K; Irwin S; Kendall M; Mack A
    J Mol Biol; 1990 Dec; 216(4):873-82. PubMed ID: 2266559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS/HIV. A reversal of fortune in HIV-1 integration.
    Engelman A
    Science; 2007 Jun; 316(5833):1855-7. PubMed ID: 17600205
    [No Abstract]   [Full Text] [Related]  

  • 13. Intein-mediated rapid purification of Cre recombinase.
    Cantor EJ; Chong S
    Protein Expr Purif; 2001 Jun; 22(1):135-40. PubMed ID: 11388811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific recombination in eukaryotic cells mediated by mutant lambda integrases: implications for synaptic complex formation and the reactivity of episomal DNA segments.
    Christ N; Corona T; Dröge P
    J Mol Biol; 2002 May; 319(2):305-14. PubMed ID: 12051908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deletion mutation on the recombination activity of Cre recombinase.
    Rongrong L; Lixia W; Zhongping L
    Acta Biochim Pol; 2005; 52(2):541-4. PubMed ID: 15912212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed integration system using a combination of mutant lox sites for Corynebacterium glutamicum.
    Suzuki N; Inui M; Yukawa H
    Appl Microbiol Biotechnol; 2007 Dec; 77(4):871-8. PubMed ID: 17938910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of spacer regions derived from intramolecular recombination between heterologous loxP sites.
    Jung UJ; Park S; Lee G; Shin HJ; Kwon MH
    Biochem Biophys Res Commun; 2007 Nov; 363(1):183-9. PubMed ID: 17826735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cre-mediated site-specific cassette exchange in erythroid cell.
    Li XG; Yan HH; Liu DP; Hao DL; Liang CC
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):947-51. PubMed ID: 14515215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia.
    McDermott JL; Martini I; Ferrari D; Bertolotti F; Giacomazzi C; Murdaca G; Puppo F; Indiveri F; Varnier OE
    J Clin Microbiol; 2005 Oct; 43(10):5272-4. PubMed ID: 16207994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.